glp-1 united healthcare Medications for Weight Loss Glucagon-like peptide-1 receptor agonists in

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The handling editor declared a past co-authorship with the authors

doi: 10.3389/fnut.2023.1324691 14 ChenQ.LiuM.ZhangP.FanS.HuangJ.YuS.et al

Recent studies identify a mechanistic link between a Western diet, gut microbiotadependent metabolism, and development of both cardiovascular disease (CVD) and metabolic diseases (13)

This study evaluates the efficacy of small peptides derived from pigment epithelium-derived factor (PEDF), which are known to restrict common cell death pathways associated with retinal diseases